| Followers | 1438 |
| Posts | 30133 |
| Boards Moderated | 23 |
| Alias Born | 12/10/2012 |
Tuesday, April 22, 2025 10:51:03 AM
$SHPH: Presentation tomorrow in Vegas.... now $0.27
Wonder if they have updates on their Blood Cancer or Prostate Cancer initiative.
https://www.globenewswire.com/news-release/2025/04/21/3064993/0/en/Shuttle-Pharma-to-Present-at-the-Planet-MicroCap-Showcase-VEGAS-2025-on-April-23-2025.html
https://shuttlepharma.com/shuttle-pharma-developing-pretreatment-diagnostic-blood-tests-for-prostate-cancer-files-provisional-patent-for-psma-ligand-conjugates-to-treat-prostate-cancer/
GO $SHPH
Wonder if they have updates on their Blood Cancer or Prostate Cancer initiative.
https://www.globenewswire.com/news-release/2025/04/21/3064993/0/en/Shuttle-Pharma-to-Present-at-the-Planet-MicroCap-Showcase-VEGAS-2025-on-April-23-2025.html
https://shuttlepharma.com/shuttle-pharma-developing-pretreatment-diagnostic-blood-tests-for-prostate-cancer-files-provisional-patent-for-psma-ligand-conjugates-to-treat-prostate-cancer/
GO $SHPH
Recent SHPH News
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/10/2026 09:12:25 PM
- Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows • Newsfile • 03/27/2026 12:00:00 PM
- Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows • Newsfile • 03/26/2026 08:05:00 PM
- E.F. Hutton & Co. Serves as Exclusive Placement Agent on Shuttle Pharmaceuticals’ $3.5 Million Public Offering • GlobeNewswire Inc. • 03/12/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/09/2026 12:00:18 PM
- Shuttle Pharmaceuticals Announces $3.5 Million Public Offering • Newsfile • 03/06/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 10:20:57 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/11/2026 10:03:26 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 02/11/2026 02:59:25 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2026 10:20:24 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/02/2026 01:15:52 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/02/2026 05:15:10 AM
- Utah Approves AI Prescriptions Drugs. How AI Is Saving Time, Cutting Costs - and Why Molecule.ai's Drug Discovery Platform Matters More Than Ever • Newsfile • 01/13/2026 09:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2026 09:16:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2025 09:05:50 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/11/2025 10:31:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2025 10:31:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/26/2025 05:28:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2025 09:05:45 PM
- Shuttle Pharmaceuticals Acquires AI Health Platform • Newsfile • 11/21/2025 02:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 11/18/2025 10:00:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/17/2025 09:05:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 03:04:43 PM
